Concomitant use of dronedarone with dabigatran in patients with atrial fibrillation in clinical practice.
Research output: Contribution to journal › Article
Dronedarone is a strong P-glycoprotein inhibitor with a potential to increase bioavailability of dabigatran. We sought to measure and report plasma concentrations of dabigatran in patients with atrial fibrillation (AF) on concomitant dronedarone treatment.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2015|
Related research output
Natalia Mochalina, 2017, Lund: Lund University: Faculty of Medicine. 81 p.
Research output: Thesis › Doctoral Thesis (compilation)